Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A

International Journal of Cancer

Volumn 72, Issue 2, 1997, Pages 340-344

  Cassoni, Paola ^a   Sapino, Anna ^a   Fortunati, Nicoletta ^a   Munaron, Luca ^a   Chini, Bice ^b   Bussolati, Gianni ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Dept of Biomed Sci and Oncology ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; FURA 2 ACETOXYMETHYL ESTER; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; OXYTOCIN; PHOSPHATIDYLINOSITIDE; PROTEIN TYROSINE KINASE;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; MYOEPITHELIUM CELL; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL DIVISION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; HUMANS; OXYTOCIN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0030745683     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970717)72:2<340::AID-IJC23>3.0.CO;2-I     Document Type: Article

References (25)

1. ALMERS, W. and NEHER, E., The Ca signal from fura-2 loaded mast cells depends on the method of dye-loading. FEBS Lett., 192, 13-18 (1985).
2. ANTONIOTTI, S., TAVERNA, D., MAGGIORA, P., SAPEI, M.L., HYNES, N.E. and DE BORTOLI, M., Oestrogen and epidermal growth factor down regulate erbB-2 oncogene protein expression in breast cancer cells by different mechanisms. Brit. J. Cancer, 70, 1095-1101 (1994).
3. ANWER, K., HOVINGTON, J.A. and SANBORN, B.M., Antagonism of contractants and relaxants at the level of intracellular calcium and phosphoinositide turnover in the rat uterus. Endocrinology, 124, 2995-3002 (1989).
4. BERRIDGE, M.J., DOWNES, C.P. and HANLEY, M.R., Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J., 206, 587-595 (1982).
5. BUSSOLATI, G., CASSONI, P., GHISOLFI, G., NEGRO, F. and SAPINO, A., Immunolocation and gene expression of oxytocin receptors in carcinomas and non-neoplastic tissues of the breast. Amer. J. Pathol., 148, 1895-1903 (1996).
6. CASSONI, P., SAPINO, A., NEGRO, F. and BUSSOLATI, G., Oxytocin inhibits proliferation of human breast cancer cell lines. Virchows Arch., 425, 467-472 (1994).
7. CASSONI, P., SAPINO, A., PAPOTTI, M. and BUSSOLATI, G., Oxytocin and oxytocin-analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas. Int. J. Cancer, 66, 817-820 (1996).
8. CHO-CHUNG, Y.S., Hypothesis: cyclic AMP and its receptor protein in-tumor growth regulation in vivo. J. cycl. Nucleotide Res., 6, 163-177 (1980).
9. CHO-CHUNG, Y.S. and GULLINO, P.M., In vivo inhibition of growth of two hormone-dependent mammary tumors by dibutyryl cyclic AMP. Science, 183, 87-88 (1974).
10. COFFINO, P., GRAY, J.W. and TOMKINS, G.M., Cyclic AMP, a non-essential regulator of the cell cycle. Proc. nat. Acad. Sci. (Wash.), 72, 878-882 (1975).
11. COOK, S.J. and MCCORMICK, F., Inhibition by cAMP of Ras-dependent activation of Raf. Science, 262, 1069-1072 (1993).
12. FUCHS, A.R., Prostaglandin F2α and oxytocin interactions in ovarian and uterine function. J. Steroid. Biochem., 27, 1073-1080 (1987).
13. FUCHS, A.R., HUSSLEIN, P. and FUCHS, F., Oxytocin and initiation of human parturition. II. Stimulation of prostaglandin production in human decidua by oxytocin. Amer. J. Obstet. Gynecol., 141, 694-697 (1981).
14. 2+ indicators with greatly improved fluorescence properties. J. biol. Chem., 260, 3440-3450 (1985).
15. ITO, Y., YASUHIRO, I., KOBAYASHI, T., KIMURA, T., MATSUURA, N., WAKASUGI, E., TAKEDA, T., SHIMANO, T., KUBOTA, Y. NOBUNAGA, T., MAKINO, Y., AZUMA, C. SAJI, F. and MONDEN, M., Investigation of the oxytocin receptor expression in human breast cancer tissue using newly established monoclonal antibodies. Endocrinology, 137, 773-779 (1996).
16. MAGGI, M., BALDI, E. and SUSINI, T., Hormonal and local regulation of uterine activity during parturition: part I. The oxytocin system. J. Endocrinol. Invest., 17, 739-756 (1994).
17. OHMICHI, M., KOIKE, K., NOHARA, A., KANDA, Y., SAKAMOTO, Y., ZHANG, Z.X., HIROTA, K. and MIYAKE, A., Oxytocin stimulates mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cells. Endocrinology, 136, 2082-2087 (1995).
18. OLINS, G.M. and BREMEL, R.D., Oxytocin-stimulated myosin phosphorylation in mammary myoepithelial cells: roles of calcium ions and cyclic nucleotides. Endocrinology, 114, 1617-1625 (1984).
19. ROBERTS, J.S., MCCRACKEN, J.A., GAVAGAN, J.E. and SOLOFF, M.S., Oxytocin-stimulated release of prostaglandin F2α from ovine endometrium in vitro: correlation with estrous cycle and oxytocin-receptors binding. Endocrinology, 99, 1107-1114 (1976).
20. SAPINO, A., MACRI, L., TONDA, L. and BUSSOLATI, G., Oxytocin enhances myoepithelial cell differentiation and proliferation in the mouse mammary gland. Endocrinology, 133, 838-842 (1993).
21. SEWEN, K. and POUYSSEGUR, J.J., Protein controlled signal transduction pathways and the regulation of cell proliferation. Adv. Cancer Res., 58, 75-94 (1992).
22. STARZEC, A.B., SPANKIS, E., NEHEME, A., SALLE, V., VEBER, N., MAINGUENE, C., PLANCHON, P., VALETTE, A., PREVOST, G. and ISRAEL, L., Proliferative response of epithelial cells to 8-bromo-cyclic AMP and to a phorbol ester change during breast pathogenesis. J. cell. Physiol., 161, 31-38 (1994).
23. TAGLIAFERRI, P. and 12 OTHERS, Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic cAMP analogues. Cancer Res., 48, 1642-1650 (1988).
24. TAYLOR, A.H., ANG, V.T.Y., JENKINS, J.S., SILVERLIGHT, J.J., COOMBES, R.C. and LUOMANI, Y.A., Interaction of vasopression and oxytocin with human breast carcinoma cells. Cancer Res., 50, 7882-7886 (1990).
25. TORTORA, G., TAGLIAFERRI, P., CLAIR, T., COLAMONICI, O., NECKERS, L., ROBINS, R.K. and CHO-CHUNG, Y.S., Site-selective cAMP analogs at micromolar concentrations induce growth arrest and differentiation of acute promyelocytic, chronic myelocytic and acute lymphocytic human leukemia cell lines. Blood, 71, 230-233 (1988).